Literature DB >> 8520749

The natural history of respiratory symptoms in preschool children.

A M Brooke1, P C Lambert, P R Burton, C Clarke, D K Luyt, H Simpson.   

Abstract

We studied the natural history of preschool respiratory symptoms in a population-based sample of children followed during the early school years. Current symptoms, ventilatory function, bronchial responsiveness to methacholine (BR), atopic status, and peak expiratory flow variability (PEFV) were assessed. Among those initially asymptomatic (210 subjects), 83.3% remained symptom-free, 6.7% started to wheeze, and 10% developed recurrent cough. Nearly half (46.9%) of the initial wheezing group (145 subjects) became symptom-free, 37.9% continued to wheeze, and 15.2% reported recurrent cough. Over half (56.0%) of the cough group (127 subjects) became symptom-free, 7.2% developed wheeze, and 36.8% reported continuing cough. Preschool wheezers showed the greatest BR (geometric mean 1.91 mg/ml) and the highest atopic prevalence (AP) (43.6%) when compared with the preschool asymptomatic group (BR: 3.39 mg/ml; AP: 23.8%) and the cough group (BR: 2.62 mg/ml; AP: 26.7%) (p = 0.0001 and p = 0.006 respectively). Children whose wheeze had persisted from the preschool period exhibited the poorest ventilatory function, the highest BR, a high AP, and high PEFV. The study shows that fewer than half of preschool wheezy children continued to wheeze in the early school years but those with persistent wheeze display many of the clinical characteristics consistent with a diagnosis of asthma.

Entities:  

Mesh:

Year:  1995        PMID: 8520749     DOI: 10.1164/ajrccm.152.6.8520749

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  How much asthma is really attributable to atopy?

Authors:  N Pearce; J Pekkanen; R Beasley
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Coughs and wheezes spread diseases: but what about the environment?

Authors:  A Bush
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 3.  Treatment of childhood asthma. Options and rationale for inhaled therapy.

Authors:  C V Powell; M L Everard
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 4.  Bronchiolitis and asthma in infancy and early childhood.

Authors:  S Godfrey
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 5.  Corticosteroid-sparing options in the treatment of childhood asthma.

Authors:  P J Helms
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health.

Authors:  Mariam El-Zein; Florence Conus; Andrea Benedetti; Dick Menzies; Marie-Elise Parent; Marie-Claude Rousseau
Journal:  Am J Epidemiol       Date:  2017-08-01       Impact factor: 4.897

7.  Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid.

Authors:  M J Davies; P Fuller; A Picciotto; S A McKenzie
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

8.  Stability of respiratory symptoms in unlabelled wheezy illness and nocturnal cough.

Authors:  C V Powell; R A Primhak
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

9.  Characterisation of atopic and non-atopic wheeze in 10 year old children.

Authors:  R J Kurukulaaratchy; M Fenn; S Matthews; S H Arshad
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 10.  Inhaled beta2-agonists for treating non-specific chronic cough in children.

Authors:  A A T Tomerak; H Vyas; M Lakenpaul; J J M McGlashan; M McKean
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.